HeXun Biosciences Co., Ltd.
6986
Rank in Stocks
#21969
HeXun Biosciences Co., Ltd., a Taiwanese enterprise, focuses on the research,... HeXun Biosciences Co., Ltd., a Taiwanese enterprise, focuses on the research, development, and application of stem cell technologies and treatments. The company also offers a comprehensive suite of related services, including contract development and manufacturing for various cell types and their derivatives, outsourced production capabilities, quality control inspections, expert consulting, laboratory information management system (LIMS) implementation, and sterile (aseptic) filling solutions. Founded in 2019, its operations are headquartered in Taoyuan City, Taiwan.
Share Price
$1.15
Last synced: 2026-11-10
Market Cap
$60.07M
Change (1 day)
-3.08%
Change (1 year)
-31.32%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade HeXun Biosciences Co., Ltd. (6986)
Category
Healthcare
Operating Margin for HeXun Biosciences Co., Ltd. (6986)
Operating Margin as of November 2026 TTM: 42.36%
According to HeXun Biosciences Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 42.36%. At the end of 2025 the company had an operating margin of 40.24%.
Operating Margin history for HeXun Biosciences Co., Ltd. from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 42.36% | 5.27% |
| 2025 | 40.24% | -25.99% |
| 2024 | 54.37% | 159.40% |
| 2023 | 20.96% | -392.33% |
| 2022 | -7.17% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -99.09% |
US
|
|
| -149.01% | -103.52% |
US
|
|
| 25.57% | -99.40% |
AU
|
|
| 31.23% | -99.26% |
BE
|
|
| 29.35% | -99.31% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about HeXun Biosciences Co., Ltd.'s operating margin
What is HeXun Biosciences Co., Ltd.'s operating margin?
HeXun Biosciences Co., Ltd.'s operating margin is 42.36%, as of Nov 2026.
What was HeXun Biosciences Co., Ltd.'s operating margin in 2025?
In 2025, HeXun Biosciences Co., Ltd.'s operating margin was 40.24%, compared with 54.37% in 2024.
How has HeXun Biosciences Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, HeXun Biosciences Co., Ltd.'s operating margin was highest in 2024 (54.37%) and lowest in 2022 (-7.17%).
How does HeXun Biosciences Co., Ltd.'s operating margin compare with similar companies?
HeXun Biosciences Co., Ltd.'s operating margin (42.36%) is higher than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.